Robert George Will

Robert George Will's AcademicInfluence.com Rankings

Robert George Will

Political Science

#3047

World Rank

#3567

Historical Rank

political-science Degrees

Download Badge

Political Science

Robert George Will's Degrees

PhD Politics Princeton University

Why Is Robert George Will Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert George Will's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A new variant of Creutzfeldt-Jakob disease in the UK (1996) (2577)
Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent (1997) (2008)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease (2009) (782)
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. (1999) (576)
Genetic prion disease: the EUROCJD experience (2005) (403)
Diagnosis of new variant Creutzfeldt‐Jakob disease (2000) (402)
"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease (1992) (370)
Quantifying prion disease penetrance using large population control cohorts (2016) (352)
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease (2000) (338)
Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada (2005) (329)
New variant Creutzfeldt-Jakob disease. (1999) (312)
Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease (2012) (305)
A prion protein epitope selective for the pathologically misfolded conformation (2003) (288)
Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment (2012) (277)
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. (2001) (269)
Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. (2003) (264)
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. (2004) (261)
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. (2006) (261)
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans (1997) (259)
Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene (1996) (240)
Acquired prion disease: iatrogenic CJD, variant CJD, kuru. (2003) (238)
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy (1999) (235)
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. (1984) (224)
Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study (2006) (221)
Predicting the CJD epidemic in humans (1997) (209)
Evidence for case-to-case transmission of Creutzfeldt-Jakob disease (1982) (209)
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. (2006) (198)
Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties (2010) (191)
Descriptive epidemiology of Creutzfeldt‐Jakob disease in six european countries, 1993–1995 (1998) (188)
Laboratory diagnosis of variant Creutzfeldt–Jakob disease (2000) (178)
Use of 14–3–3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease (2001) (176)
First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features (2002) (173)
MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. (2001) (169)
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. (1988) (166)
Prion protein heterogeneity in sporadic but not variant Creutzfeldt–Jakob disease: U.K. cases 1991–2002 (2004) (150)
Risk factors for Creutzfeldt‐Jakob disease (1996) (137)
The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. (1992) (134)
Abbreviated incubation times for human prions in mice expressing a chimeric mouse–human prion protein transgene (2003) (130)
Changing a single amino acid in the N‐terminus of murine PrP alters TSE incubation time across three species barriers (2001) (126)
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review (2010) (126)
Iatrogenic Creutzfeldt‐Jakob disease (1994) (122)
Risk factors for variant Creutzfeldt–Jakob disease: A case–control study (2006) (122)
Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. (2012) (119)
Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease (1996) (115)
Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome: Population-Based Study (2015) (114)
Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96 (1997) (114)
Tissue Handling in Suspected Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) (1995) (108)
The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia (1991) (107)
Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK (2003) (104)
Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease (2016) (101)
Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the “Heidenhain variant” (2005) (94)
Creutzfeldt–Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study (2006) (93)
Epidemiology of Creutzfeldt-Jakob disease. (1993) (91)
Obstacles to conducting epidemiological research in the UK general population (2004) (90)
Validation of diagnostic criteria for variant Creutzfeldt–Jakob disease (2010) (88)
Creutzfeldt-Jakob disease and blood transfusion (1993) (77)
A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. (1996) (71)
A prion disease with a novel 96-base pair insertional mutation in the prion protein gene (1996) (70)
PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism (2009) (69)
Kleine-Levin Syndrome: Report of Two Cases with Onset of Symptoms Precipitated by Head Trauma (1988) (68)
Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970-84. (1990) (66)
Creutzfeldt-Jakob disease: recent developments (2017) (65)
The epidemiology of progressive intellectual and neurological deterioration in childhood (2009) (64)
Comparative evidence for a link between Peyer's patch development and susceptibility to transmissible spongiform encephalopathies (2006) (64)
MM2‐Thalamic Creutzfeldt–Jakob Disease: Neuropathological, Biochemical and Transmission Studies Identify a Distinctive Prion Strain (2012) (63)
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979. II: Epidemiology. (1986) (60)
Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt–Jakob disease (2013) (60)
Variant Creutzfeldt–Jakob disease in France and the United Kingdom: Evidence for the same agent strain (2009) (59)
Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting. (1997) (58)
Variant CJD (2014) (55)
PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease. (2002) (53)
Dura mater-associated Creutzfeldt–Jakob disease: experience from surveillance in the UK (2006) (53)
Risk factors for sporadic Creutzfeldt–Jakob disease (2008) (53)
The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt–Jakob disease (2009) (50)
Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease (2006) (49)
Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. (1993) (49)
Three reported cases of variant Creutzfeldt–Jakob disease transmission following transfusion of labile blood components (2006) (49)
Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. (1995) (48)
Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt–Jakob disease (2000) (48)
NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease (2012) (46)
A case of progressive subcortical gliosis presenting clinically as Steele-Richardson-Olszewski syndrome. (1988) (44)
Intensity of human prion disease surveillance predicts observed disease incidence (2013) (44)
Sporadic Creutzfeldt–Jakob disease with cerebellar ataxia at onset in the UK (2006) (43)
12 Infectious and Sporadic Prion Diseases (1999) (43)
Diagnosing variant Creutzfeldt–Jakob disease: a retrospective analysis of the first 150 cases in the UK (2010) (41)
The clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration: a national, prospective, population‐based study (2009) (40)
Creutzfeldt–Jakob Disease and the Risk from Blood or Blood Products (1998) (40)
Variations in neurodegenerative disease across the UK: findings from the national study of Progressive Intellectual and Neurological Deterioration (PIND). (2004) (40)
Periodic electroencephalogram complexes in a patient with variant Creutzfeldt–Jakob disease (2006) (40)
Ophthalmic surgery and Creutzfeldt-Jakob disease (2004) (38)
Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk (2012) (38)
Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE (1993) (38)
Sporadic and Infectious Human Prion Diseases. (2017) (37)
Intracerebral distribution of infectious amyloid protein in spongiform encephalopathy (1995) (37)
Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. (2001) (36)
Neuropathological phenotype and ‘prion protein’ genotype correlation in sporadic Creutzfeldt-Jakob disease (1994) (36)
The epidemiology of variant Creutzfeldt-Jakob disease. (2004) (34)
Variant Creutzfeldt‐Jakob disease in a transfusion recipient: coincidence or cause? (2010) (33)
MHC typing in variant Creutzfeldt-Jakob disease (2003) (32)
No Major Change in vCJD Agent Strain after Secondary Transmission via Blood Transfusion (2008) (32)
Source of Variant Creutzfeldt-Jakob Disease outside United Kingdom (2007) (31)
A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom (2004) (31)
Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt-Jakob disease in the squirrel monkey (Saimiri sciureus). (2007) (30)
The pulvinar sign in variant Creutzfeldt-Jakob disease. (2004) (30)
The neuropsychological profile associated with variant Creutzfeldt-Jakob disease. (2003) (29)
Is there the potential for an epidemic of variant Creutzfeldt–Jakob disease via blood transfusion in the UK? (2007) (29)
A retrospective case note review of deceased recipients of vCJD‐implicated blood transfusions (2009) (29)
Creutzfeldt-Jakob disease in the elderly. (1997) (27)
Isolated intracranial hypertension presenting with trigeminal neuropathy. (1994) (27)
Sensitivity to Biases of Case-Control Studies on Medical Procedures, Particularly Surgery and Blood Transfusion, and Risk of Creutzfeldt-Jakob Disease (2012) (27)
A Genome Wide Association Study Links Glutamate Receptor Pathway to Sporadic Creutzfeldt-Jakob Disease Risk (2015) (26)
A report of Froin's syndrome in five ovine thoracolumbar epidural abscess cases. (1991) (26)
Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate (2014) (26)
Diagnosing Creutzfeldt-Jakob disease (1996) (26)
Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010. (2012) (25)
Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease (1996) (25)
Amount of research interest in rare and common neurological conditions: bibliometric study (2001) (25)
Variant CJD and blood transfusion: are there additional cases? (2014) (25)
Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges (2018) (25)
Clinical features of variant Creutzfeldt-Jakob disease. (2004) (25)
Constant Transmission Properties of Variant Creutzfeldt-Jakob Disease in 5 Countries (2012) (24)
Psychiatric features of new variant Creutzfeldt-Jakob disease (1999) (24)
MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter‐observer agreement study (2008) (24)
Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification (2018) (24)
Variant Creutzfeldt-Jakob disease. (2003) (23)
Prions and the Oral Cavity (2003) (23)
Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis (2003) (23)
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979. II: Epidemiology (1987) (23)
A polymorphism in the regulatory region of PRNP is associated with increased risk of sporadic Creutzfeldt-Jakob disease (2011) (23)
Surveillance of Prion Diseases in Humans (1996) (23)
PRION DISEASES (2004) (22)
13 Infectious and Sporadic Prion Diseases (2004) (22)
Predicting the size of the vCJD epidemic in France. (2002) (22)
Central and peripheral SEP defects in neurologically symptomatic and asymptomatic subjects with low vitamin B12 levels (1987) (21)
Variant Creutzfeldt-Jakob disease: costs borne by families. (2002) (21)
Cerebrospinal fluid studies in normal cows and cases of bovine spongiform encephalopathy. (1990) (21)
Familial multiple sclerosis (1988) (21)
Prion Related Disorders (1999) (20)
Dental treatment and risk of variant CJD – a case control study (2007) (20)
Magnetic resonance imaging in Creutzfeldt‐Jakob disease (1992) (20)
Diagnosis of Creutzfeldt-Jakob disease (1999) (19)
Public health risks from subclinical variant CJD (2017) (19)
Variant Creutzfeldt‐Jakob disease and exposure to fractionated plasma products (2009) (19)
Variant Creutzfeldt-Jakob disease. (2003) (19)
Factors determining the potential for onward transmission of variant Creutzfeldt–Jakob disease via surgical instruments (2006) (18)
Sporadic Creutzfeldt–Jakob disease in two adolescents (2007) (17)
A case of progressive subcortical gliosis associated with deposition of abnormal prion protein (PrP) (1995) (17)
The end of the BSE saga: do we still need surveillance for human prion diseases? (2015) (16)
Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease. (2006) (16)
Type of prion protein in UK farmers with Creutzfeldt-Jakob disease (1997) (16)
Bovine spongiform encephalopathy in a cow in the United Kingdom. (1989) (16)
CREUTZFELDT-JAKOB DISEASE IN A LIFELONG VEGETARIAN (1981) (16)
Prion diseases. (2004) (15)
Sporadic Creutzfeldt‐Jakob disease and risk of blood transfusion in the United Kingdom (2011) (15)
Oral infection by the bovine spongiform encephalopathy prion. (1999) (14)
Moratorium on Kveim test (1993) (14)
Disinfection and Sterilization of Prion-Contaminated Medical Instruments (2010) (14)
Creutzfeldt-Jakob disease Failure to detect spiroplasmas by cultivation and serological tests (1983) (13)
Is there evidence of vertical transmission of variant Creutzfeldt–Jakob disease? (2009) (13)
Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom (2017) (12)
The spongiform encephalopathies. (1991) (12)
Ten‐year follow‐up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at‐risk donors (2016) (11)
Quantification of Peyer's patches in Cheviot sheep for future scrapie pathogenesis studies. (2007) (11)
Minimise transmission risk of CJD and vCJD in healthcare settings. Report on the Prevention of CJD and vCJD by Advisory Committee on Dangerous Pathogens' Transmission Spongiform Encephalopathy (ACDP TSE) Subgroup. (2015) (11)
Creutzfeldt-Jakob disease in elderly people. (2002) (11)
The geographical distribution of variant Creutzfeldt-Jakob disease cases in the UK: what can we learn from it? (2003) (11)
Faculty Opinions recommendation of Transmission of neurodegenerative disorders through blood transfusion: A cohort study. (2017) (10)
FFI Cases from the United Kingdom (1998) (10)
Brain abscess complicating ischemic stroke. (1995) (10)
Isolated language impairment as the primary presentation of sporadic Creutzfeldt Jakob Disease (2017) (9)
Variant Creutzfeldt-Jakob disease in older patients (2015) (9)
The pulvinar sign and diagnosis of Creutzfeldt-Jakob disease. (2002) (9)
[Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action]. (1996) (9)
α‐Hemoglobin stabilizing protein is not a suitable marker for a screening test for variant Creutzfeldt‐Jakob disease (2008) (8)
Creutzfeldt-Jakob disease and urinary gonadotrophins. (2004) (8)
Epidemiological surveillance of Creutzfeldt-Jakob disease in the United Kingdom (1991) (8)
Genetic Creutzfeldt–Jakob disease mimicking variant Creutzfeldt–Jakob disease (2009) (8)
An application of hidden Markov models to the French variant Creutzfeldt–Jakob disease epidemic (2010) (8)
No clinical evidence of hidden vCJD in UK children (2005) (8)
Bovine spongiform encephalopathy and risk to health. (1992) (7)
Risk factors for variant Creutzfeldt-Jakob disease in dental practice: a case-control study (2012) (7)
A new prionopathy (2008) (7)
Variant Creutzfeldt-Jakob disease. (2002) (7)
Gene influences on Creutzfeldt-Jakob disease (1994) (6)
Greenfiled’s Neuropathology (2008) (6)
Brain biopsy and patients with atypical presentations of sporadic Creutzfeldt- Jakob disease (1997) (6)
The first case of variant Creutzfeldt-Jakob disease in the Netherlands (2007) (6)
A study of flame arrestors in piping systems. Even officially approved flame arrestors must be used only under the exact conditions for which they were tested and approved (1983) (6)
Commentary: The risk of variant Creutzfeldt-Jakob Disease: reassurance and uncertainty. (2004) (6)
[A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone]. (1996) (5)
vCJD: the epidemic that never was (2002) (5)
Incidence of Creutzfeldt-Jakob Disease in the European Community (1996) (5)
New variant Creutzfeldt-Jakob disease. (1998) (5)
Similarities of Variant Creutzfeldt-Jakob Disease Strain in Mother and Son in Spain to UK Reference Case (2017) (5)
Creutzfeldt-Jakob disease in Scotland and Northern Ireland 1980-1989. (1992) (5)
Is variant Creutzfeldt-Jakob disease in young children misdiagnosed as Alpers’ syndrome? An analysis of a national surveillance study (2004) (5)
Clinical features of human prion diseases (2002) (5)
Survival and Re-Operation Rates after Neurosurgical Procedures in Scotland: Implications for Targeted Surveillance of Sub-Clinical Variant Creutzfeldt-Jakob Disease (2009) (4)
Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes (2019) (4)
Mumps and Guillain-Barré syndrome. (1990) (4)
Transmissible spongiform encephalopathies and human neurodegenerative disease. (1993) (4)
Creutzfeldt-Jakob disease. Failure to detect spiroplasmas by cultivation and serological tests. (1983) (4)
Blood safety. (1998) (4)
New variant Creutzfeldt-Jakob disease is more common in Britain than elsewhere (1998) (4)
Surveillance for variant CJD: should more children with neurodegenerative diseases have autopsies? (2018) (4)
Variant Creutzfeldt-Jakob disease. (2002) (3)
An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone. (1991) (3)
Variant Creutzfeldt-Jakob disease: Neuropsychological profile in an extended series of cases (2009) (3)
The new variant of CJD (1999) (2)
Bovine Spongiform Encephalopathy (BSE) (2005) (2)
Clinical aspects of variant Creutzfeldt-Jakob disease. (2008) (2)
Variant Creutzfeldt-Jakob disease is not associated with individual abilities to metabolise organophosphates (2001) (2)
Creutzfeldt‐Jakob Disease and the Risk from Blood or Blood Products (1998) (2)
No Adaptation of the Prion Strain in a Heterozygous Case of Variant Creutzfeldt-Jakob Disease (2020) (2)
A neurosurgical Munchausen revisited. (1992) (2)
The biology and epidemiology of variant Creutzfeldt-Jakob disease. (2003) (2)
Is sporadic CJD an acquired disease? A review of the UK CJD cases. (2016) (1)
Commentary: Scrapie revisited (1995) (1)
Faculty Opinions recommendation of Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: An international study. (2017) (1)
Accuracy of a history of blood donation from surrogate witnesses: data from the UK TMER study (2018) (1)
Case Report Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease (2006) (1)
Reply to “Properties of a disease-specific prion probe” (2004) (1)
An update on variant CJD (vCJD), secondary transmission and prevalence (2006) (1)
Quality of paediatric care at King Edward VIII hospital. (1987) (1)
THE DIAGNOSTIC UTILITY OF RT-QUIC IN SPORADIC CJD (2014) (1)
The transmission of prion disease: Response to the article: ‘Vertical transfer of prion disease’ by Lacey and Dealler (1994) (1)
UPDATE ON BSE AND VARIANT CJD (2002) (1)
36. Variant Creutzfeldt–Jakob Disease (2011) (1)
Evaluating the species barriers of TSEs with transgenic mouse models (2016) (1)
The neuropsychological pro ® le associated with variant Creutzfeldt ± Jakob disease (2003) (1)
Prions and Agents of TSEs: Creutzfeldt–Jakob Disease (2014) (1)
Human prion diseases (2010) (1)
Variant CJD: Lessons in public health (2016) (1)
Diagnosis of Methionine/Valine Variant Creutzfeldt - Jakob disease using PMCA in Cerebrospinal fluid (2018) (0)
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the United Kingdom: a 10 year review (2020) (0)
NEUROPSYCHIATRIC ASPECTS OF VARIANT CREUTZFELDT-JAKOB DISEASE (2003) (0)
Faculty Opinions recommendation of Prions in the urine of patients with variant Creutzfeldt-Jakob disease. (2017) (0)
Diagnosis of Variant Creutzfeldt - Jakob Disease Using Protein Misfolding Cyclic Amplification (PMCA) (2018) (0)
Cold comfort pharm (2008) (0)
Use of cerebrospinal fluid 14-3-3 analysis in the diagnosis of sporadic and variant Creutzfeldt-Jakob disease (2002) (0)
CHARACTERISTICS AND DISTRIBUTION OF PrP IN THE NEW VARIANT OF CREUTZFELDT-JAKOB DISEASE (1997) (0)
Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes (2019) (0)
Variant Creutzfeldt-Jakob disease: An epidemiological update in relation to geographically associated cases and history of vaccination (2003) (0)
A common strain of agent is present in variant CJD cases from five different countries (2010) (0)
Faculty Opinions recommendation of Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. (2017) (0)
VARIANT CREUTZFELDT-JAKOB DISEASE AND BOVINE SPONGIFORM ENCEPHALOPATHY: CURRENT STATUS (2003) (0)
TECHNICAL SUPPORT OF SPILL CONTROL OPERATIONS (1977) (0)
Faculty of 1000 evaluation for Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. (2017) (0)
No adaption of the prion strain in a heterozygous case of variant Creutzfeldt-Jakob disease (2020) (0)
SP3-35 Investigating dental treatment as a possible risk factor for variant Creutzfeldt-Jakob Disease (vCJD) in the UK (2011) (0)
Protein Structure and Biology (2013) (0)
Faculty Opinions recommendation of Excretion of transmissible spongiform encephalopathy infectivity in urine. (2008) (0)
Explorer Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease (2016) (0)
Properties of a disease-specific prion probe [1] (multiple letters) (2004) (0)
BRAIN ABSCESS COMPLICATING ISCHEMIC STROKE. AUTHORS' REPLY (1995) (0)
Dedication, yet uncertainty (2003) (0)
Reply (2011) (0)
vCJD Case Studies (2018) (0)
Diagnosis of sporadic Creutzfeldt-Jakob disease using the putamen intensity gradient (2003) (0)
VARIANT CJD PRESENTS DIFFERENTLY IN OLDER PATIENTS (2013) (0)
How new is new? (2002) (0)
Response to the Article by Adanipar et al.: The First Report of a Patient with Probable Variant Creutzfeldt-Jakob Disease in Turkey, Dement Geriatr Cogn Disord Extra 2011;1:429–432 (2012) (0)
Faculty of 1000 evaluation for Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK. (2017) (0)
Cold comfort pharm (2009) (0)
In Both Cjd4 and Gerstmann-straussler Syndrome,5 And (0)
New variant Creutzfeldt-Jakob disease : Safety of Biological Products Prepared from Mammalian Cell Culture (1998) (0)
The EEG in sporadic Creutzfeldt-Jakob disease (2007) (0)
CSF 14-3-3 IS MORE SENSITIVE THAN CSF TAU PROTEIN FOR THE DIAGNOSIS OF SPORADIC CREUTZFELDT-JAKOB DISEASE (2009) (0)
Diagnosis of Variant Creutzfeldt - Jakob Disease in life Using Protein Misfolding Cyclic Amplification (PMCA). (2018) (0)
Explorer Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease (2017) (0)
Bovine Spongiform Encephalopathy (2008) (0)
Editorial (2003) (0)
Prion disease (1990) (0)
CHAPTER 95 – PRION DISEASES (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert George Will?

Robert George Will is affiliated with the following schools:

University of Edinburgh